Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for <b><i>Helicobacter pylori</i></b> — Teppei Adachi (2017) | RDL Network
Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for <b><i>Helicobacter pylori</i></b>
Article 2017 en
Authors
TA
Teppei Adachi
SM
Shigenaga Matsui
TW
Tomohiro Watanabe
Abstract
1 min read
MNZ-based triple therapy consisting of esomeprazole and amoxicillin is superior to CAM-based triple therapy containing esomeprazole and amoxicillin as first-line eradication treatment against H. pylori.
Mojtaba Kamankesh, Abbas Yadegar, Antoni Llopis‐Lorente, Chenguang Liu, Ismaeil Haririan, Hamid Asadzadeh Aghdaei, Mohammad Ali Shokrgozar, Mohammad Reza Zali, Amir Hossein Miri, Mazda Rad‐Malekshahi, Michael R Hamblin, Matthias G. Wacker
Anthony Lembo, Robert A. Ganz, Sunil G. Sheth, David R. Cave, Ciarán P. Kelly, П. В. Левин, Peter T. Kazlas, Paul C. Baldwin, William R. Lindmark, Jonathan R. McGrath, Michael R Hamblin
Discussion(0)
No comments yet. Be the first to comment.